- The Amgen Virtual Congress Platform is an online destination for timely, relevant, scientific data.
- As a values-based company, Amgen strives to provide relevant information rooted in science and innovation to transform new ideas and discoveries into treatments for patients with serious illnesses.
- If you would like more information about Amgen and its business, please visit About Amgen.
FAQ
Here are some of the Amgen Virtual Congress Platform frequently asked questions
What is the Amgen Virtual Congress Platform?
Who is the Amgen Virtual Congress Platform for?
- The Virtual Congress Platform is for members of the medical community (healthcare practitioners, associated team members, payors, and academics) seeking flexible access to conference materials from Amgen—no sign-up required.
- The Virtual Congress Platform brings desired content to in-person and remote attendees looking for more information.
What therapeutic areas does the Amgen Virtual Congress Platform cover?
- This site focuses on six therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation.
- Our medicines typically address diseases for which there are limited treatment options or seek to fulfill an unmet need.
How often should I check back for updates?
- Please review the Amgen Congress Platform schedule for upcoming congresses that may be of interest to you.
How do I learn more about the pipeline and clinical trials?
- Please visit Amgen Pipeline and Clinical Trials for more information on our robust pipeline, which leverages state-of-the-art science and molecular engineering in the pursuit of transformative medicines for large effects in serious diseases.
If I’m not able to view an abstract I’m interested in, how can I view this information?
- Please visit Amgen Medical Information to submit your request for more information.
How do I find information on a specific product?
- While our congress-specific microsites often feature products, you can find additional product information on Amgen’s Our Products page. Please note, this content is intended only for residents of the United States.
- For information regarding FDA-approved biosimilar products, please visit Amgen Biosimilars.
How can I get in touch with a Medical Science Liaison (MSL)?
- Our U.S. audience can contact an MSL using this link: Find Your Medical Science Liaison.